BSX
Price
$84.75
Change
+$0.73 (+0.87%)
Updated
Nov 4, 10:50 AM (EDT)
86 days until earnings call
ICLR
Price
$219.57
Change
-$2.54 (-1.14%)
Updated
Nov 4, 02:35 PM (EDT)
107 days until earnings call
Ad is loading...

BSX vs ICLR

Header iconBSX vs ICLR Comparison
Open Charts BSX vs ICLRBanner chart's image
Boston Scientific
Price$84.75
Change+$0.73 (+0.87%)
Volume$12.43K
CapitalizationN/A
ICON
Price$219.57
Change-$2.54 (-1.14%)
Volume$1.76K
CapitalizationN/A
View a ticker or compare two or three
BSX vs ICLR Comparison Chart
Loading...
BSX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ICLR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
BSX vs. ICLR commentary
Nov 04, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BSX is a StrongBuy and ICLR is a Hold.

COMPARISON
Comparison
Nov 04, 2024
Stock price -- (BSX: $84.02 vs. ICLR: $222.11)
Brand notoriety: BSX: Notable vs. ICLR: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BSX: 1% vs. ICLR: 0%
Market capitalization -- BSX: $100.1B vs. ICLR: $27.35B
BSX [@Medical Specialties] is valued at $100.1B. ICLR’s [@Medical Specialties] market capitalization is $27.35B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.97B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BSX’s FA Score shows that 1 FA rating(s) are green whileICLR’s FA Score has 0 green FA rating(s).

  • BSX’s FA Score: 1 green, 4 red.
  • ICLR’s FA Score: 0 green, 5 red.
According to our system of comparison, BSX is a better buy in the long-term than ICLR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BSX’s TA Score shows that 4 TA indicator(s) are bullish while ICLR’s TA Score has 4 bullish TA indicator(s).

  • BSX’s TA Score: 4 bullish, 5 bearish.
  • ICLR’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, BSX is a better buy in the short-term than ICLR.

Price Growth

BSX (@Medical Specialties) experienced а -0.84% price change this week, while ICLR (@Medical Specialties) price change was +0.74% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.13%. For the same industry, the average monthly price growth was -0.80%, and the average quarterly price growth was -1.51%.

Reported Earning Dates

BSX is expected to report earnings on Jan 29, 2025.

ICLR is expected to report earnings on Feb 19, 2025.

Industries' Descriptions

@Medical Specialties (-0.13% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BSX($100B) has a higher market cap than ICLR($27.4B). BSX has higher P/E ratio than ICLR: BSX (63.64) vs ICLR (44.81). BSX YTD gains are higher at: 45.338 vs. ICLR (-21.535). BSX has higher annual earnings (EBITDA): 3.45B vs. ICLR (1.52B). BSX has more cash in the bank: 865M vs. ICLR (380M). ICLR has less debt than BSX: ICLR (3.94B) vs BSX (9.49B). BSX has higher revenues than ICLR: BSX (14.2B) vs ICLR (8.12B).
BSXICLRBSX / ICLR
Capitalization100B27.4B365%
EBITDA3.45B1.52B227%
Gain YTD45.338-21.535-211%
P/E Ratio63.6444.81142%
Revenue14.2B8.12B175%
Total Cash865M380M228%
Total Debt9.49B3.94B241%
FUNDAMENTALS RATINGS
BSX vs ICLR: Fundamental Ratings
BSX
ICLR
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
68
Overvalued
PROFIT vs RISK RATING
1..100
1050
SMR RATING
1..100
7277
PRICE GROWTH RATING
1..100
4389
P/E GROWTH RATING
1..100
5892
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ICLR's Valuation (68) in the Pharmaceuticals Other industry is in the same range as BSX (79) in the Medical Specialties industry. This means that ICLR’s stock grew similarly to BSX’s over the last 12 months.

BSX's Profit vs Risk Rating (10) in the Medical Specialties industry is somewhat better than the same rating for ICLR (50) in the Pharmaceuticals Other industry. This means that BSX’s stock grew somewhat faster than ICLR’s over the last 12 months.

BSX's SMR Rating (72) in the Medical Specialties industry is in the same range as ICLR (77) in the Pharmaceuticals Other industry. This means that BSX’s stock grew similarly to ICLR’s over the last 12 months.

BSX's Price Growth Rating (43) in the Medical Specialties industry is somewhat better than the same rating for ICLR (89) in the Pharmaceuticals Other industry. This means that BSX’s stock grew somewhat faster than ICLR’s over the last 12 months.

BSX's P/E Growth Rating (58) in the Medical Specialties industry is somewhat better than the same rating for ICLR (92) in the Pharmaceuticals Other industry. This means that BSX’s stock grew somewhat faster than ICLR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BSXICLR
RSI
ODDS (%)
Bearish Trend 4 days ago
36%
Bullish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
58%
Bullish Trend 4 days ago
75%
Momentum
ODDS (%)
Bearish Trend 4 days ago
55%
Bearish Trend 4 days ago
57%
MACD
ODDS (%)
Bearish Trend 4 days ago
57%
Bearish Trend 4 days ago
55%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
47%
Bullish Trend 4 days ago
69%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
50%
Bearish Trend 4 days ago
62%
Advances
ODDS (%)
Bullish Trend 22 days ago
61%
Bullish Trend 7 days ago
68%
Declines
ODDS (%)
Bearish Trend 6 days ago
46%
Bearish Trend 4 days ago
59%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 4 days ago
82%
Aroon
ODDS (%)
Bullish Trend 4 days ago
58%
Bearish Trend 4 days ago
47%
View a ticker or compare two or three
Ad is loading...
BSX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ICLR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ABM53.090.03
+0.06%
ABM Industries
AMRK38.85N/A
N/A
A-Mark Precious Metals
SQM38.39N/A
N/A
Sociedad Quimica y Minera de Chile SA
MPAA5.27N/A
N/A
Motorcar Parts of America
CDIO0.28N/A
N/A
Cardio Diagnostics Holdings

BSX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BSX has been loosely correlated with SYK. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if BSX jumps, then SYK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSX
1D Price
Change %
BSX100%
N/A
SYK - BSX
66%
Loosely correlated
N/A
ISRG - BSX
53%
Loosely correlated
+0.50%
RVTY - BSX
52%
Loosely correlated
N/A
EW - BSX
43%
Loosely correlated
N/A
ABT - BSX
37%
Loosely correlated
N/A
More